Compound ID | 585
PGE 1818689
Class: Quinoyl-carbacephem
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Effective against E. coli and S. aureus; cell-wall synthesis and DNA gyrase inhibitor |
| Description: | Mallalieu NI, Bierman JC, Dorsey JS, et al. Pharmacokinetics and in vivo efficacy of quinolonyl-carbacephem antibacterials in animals. 38th-Intersci-Conf-Antimicrobial-Agents-Chemother 1998; 281. |
| Institute where first reported: | Procter Gamble Pharmaceuticals, Ireland |
| Year first mentioned: | 1998 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.